Celgene Investors: Watch This Hearing In 5 Weeks By: Benzinga via Benzinga March 31, 2015 at 12:12 PM EDT Citi issued a note on Celgene Corporation (NASDAQ: CELG) Tuesday ahead of a May 7 hearing to determine if the Revlimid EU polymorph ... Read More >> Related Stocks: Celgene Corp